Loading...
Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon
Background. Current treatment of chronic hepatitis C with pegylated interferon and ribavirin has the ability to eliminate viral infection in about half of the patients treated. Therapeutic options, for those with remaining chronic hepatitis, will remain limited until novel antivirals become availabl...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Hindawi Publishing Corporation
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3003973/ https://ncbi.nlm.nih.gov/pubmed/21188197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/537827 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|